Helicobacter pylori.
Conditions
Interventions
Intervention 1: control group : MCT supplement, 2 grams per day (twice a day, each time 1 gram), at morning and evening, and during 12 weeks. Intervention 2: intervention 1 group : moreEPA supplement,
Placebo
Treatment - Drugs
control group : MCT supplement, 2 grams per day (twice a day, each time 1 gram), at morning and evening, and during 12 weeks
intervention 1 group : moreEPA supplement, 2 gram per day (twice a day, each time 1 gram) at morning and evening, and during 12 weeks
intervention 2 group:moreDHA supplement, 2 grams per day (twice a day, each time 1 gram), at morning and evening, and during 12 weeks
Sponsors
Vive-chancellor for Research, Tehran University of Medical Sciences
Gastrointestinal & Liver Disease Research Center (Firoozgar GILDRC)
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: - positive stool antigen test result - no history of pharmaceutical treatment for infection eradication - no gastric surgery - no history of peptic ulcer - no any disease that cause inflammation & increase of serum inflammatori markers level such as diabetes, CVD, respiratoryinflammations such as asthma,... - no consumption of any drug other than prescribed drugs during the study - no consumption of antibiotic or bismut during 2 months before the trial - no consumption of antioxidant supplements such as Se, Zn, beta-caroten,... at least 3 months before the trial - no consumption of omega-3 supplements at least 3 months before the trial - no smoking - BMI less than 30 - age between 20-60 years old -leaning to cooperation Exclusion criteria: - no leaning to continuing the cooperation - any change in type or dose of prescribed drugs - any change in daily diet or physical activity - consumption of any antioxidant supplement - consumption of less than 70% of supplements given to patients at the start of the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Helicobacter pylori infection eradication. Timepoint: before & after intervention (after 12 weeks intervention). Method of measurement: stool antigen test.;Serum level of Il-6. Timepoint: before & after intervention (after 12 weeks intervention). Method of measurement: ELISA kitt.;Serum level of Il-8. Timepoint: before & after intervention (after 12 weeks intervention). Method of measurement: ELISA kitt.;Serum level of hs-CRP. Timepoint: before & after intervention (after 12 weeks intervention). Method of measurement: ELISA kitt.;Serum level of TAC. Timepoint: before & after intervention (after 12 weeks intervention). Method of measurement: colorimetry (FRAP). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Farzad Shidfar
Faculty of Public Health of Tehran University of Medical Sciences
Outcome results
None listed